Acquisition leverages Cadence’s computational software expertise into molecular modeling and simulation, focused on pharmaceutical and biotechnology drug discovery The addition of OpenEye’s ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Cadence (Nasdaq: CDNS) today announced it has entered into a definitive agreement to acquire the Design & Engineering (“D&E”) business of Hexagon AB, which includes ...

OpenEye does not develop drugs but its software is used by pharmaceutical and biotechnology companies that do. The company’s software-as-a-service offering, called Orion, provides molecular modeling ...

Imec validates Cadence LPA PLUS for advanced-process technologies Customers can verify design manufacturability during implementation and signoff, enabling them to detect and fix yield-limiting ...

SAN JOSE, Calif. & SANTA FE, N.M.--(BUSINESS WIRE)--Cadence entered into a definitive agreement to acquire OpenEye Scientific, a provider of computational molecular modeling and simulation software.